Tracheal oxalosis associated with Aspergillus niger tracheobronchitis.

REFERENCES 1 GOLD. Global Strategy for the Diagnosis, Management, and Prevention of COPD, 2011. www.goldcopd.org/Guidelines/guide lines-resources.html Date last accessed: October 1, 2012. 2 Soriano JB, Brusasco V, Dinh-Xuan AT. The European Respiratory Journal makes COPD a priority. Eur Respir J 2011; 38: 999–1001. 3 Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of COPD: identification of biological clusters and their biomarkers. Am J Respir Crit Care Med 2011; 184: 662–671. 4 Mallia P, Message SD, Gielen V, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011; 183: 734–742. 5 Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28: 1205–1210. 6 Mogelvang R, Goetze JP, Schnohr P, et al. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnoea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol 2007; 50: 1694–1701. 7 Bertoletti L, Quenet S, Mismetti P, et al. RIETE Investigators. Clinical presentation and outcome of venous thromboembolism in COPD. Eur Respir J 2012; 39: 862–868. 8 Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J 2013; 41: 815–823. 9 Chang CL, Robinson SC, Mills GD, et al. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax 2011; 66: 764–768. 10 Agusti A, Macnee W. The COPD control panel: towards personalised medicine in COPD. Thorax 2012; [in press DOI: 10.1136/thoraxjnl-2012-202772].